Topics

Companies Related to "Tocilizumab REMission in Early RA" [Most Relevant Company Matches] RSS

13:55 EST 7th December 2019 | BioPortfolio

Here are the most relevant search results for "Tocilizumab REMission in Early RA" found in our extensive corporate database of over 50,000 company records.

Showing "Tocilizumab REMission Early" Companies 1–25 of 1,200+

Relevant

EpiCept Corporation

EpiCept is focused on the development and commercialization of pharmaceutical products for the treatment of cancer and pain. The Company's lead product is Ceplene®, which has been granted full marketing authorization by the European Commission for the remission maintenance and prevention of relapse in adult patients with Acute Myeloid Leukemia (AML) in ...


Probably Relevant

BIO-LOGIC SOLUTIONS

A start-up biomedical company with a novel approach to treating cancer. Our approach is logical. There are specific chemicals associated with tumors which block immune attack. By neutralizing these chemicals and stimulating immune response, we are able to initiate a spontaneous remission of the tumor.Our treatment concept has been accepted by the Patent Cooperation Treaty (PCT) as novel, inventi...

ImmuNext, Inc.

ImmuNext is developing novel therapeutics that modulate the immune system to treat cancer and autoimmune diseases. We are targeting critical immuno-regulatory molecules that either promote or suppress immune responses to restore immune homeostasis and cure disease. Using antibody-based therapeutics and novel recombinant fusion proteins, we are developing a...


Formula Pharmaceuticals Inc.

Formula Pharmaceuticals, Inc. is a privately-held, oncology drug development company advancing novel medicines to address areas of unmet therapeutic need in cancer. Formula’s lead product candidate, FPI-01 is a first-in-class immunotherapeutic in clinical development for the maintenance of first-remission in acute myeloid leukemia (AML) and other canc...

Formula Pharmaceuticals

Formula Pharmaceuticals, Inc. is a privately-held, oncology drug development company advancing novel medicines to address areas of unmet therapeutic need in cancer. Formula’s lead product candidate, FPI-01, is a first-in-class immunotherapeutic in clinical development for the maintenance of first-remission in acute myeloid leukemia (AML) and other can...

Formula Pharmaceuticals, Inc.

Formula Pharmaceuticals, Inc. is a privately-held, oncology drug development company advancing novel medicines to address areas of unmet therapeutic need in cancer. Formula’s lead product candidate, FPI-01, is a first-in-class immunotherapeutic in clinical development for the maintenance of first-remission in acute myeloid leukemia (AML) and other can...

Fans For The Cure

Ed Randall's Fans For The Cure was founded in 2002 after the charity’s founder, Ed Randall, was diagnosed with prostate cancer. After treatment at St. Luke’s-Roosevelt Hospital, Ed's cancer went into, and remains, in remission. Ed Randall is the host of Ed Randall’s Talking Baseball on Sirius/XM Radio Channel 175 and WFAN Radio in New York. Heâ€...

Xillix Technologies Corp

Xillix, based in British Columbia, Canada, focuses on the research, development and commercialization of medical imaging technologies which aid in the early detection and localization of cancer. Detecting cancer early can often mean the difference between life and death. Since its inception Xillix has developed innovative fluorescence endoscopy systems which allow physicians to see very small, ear...

Canary Foundation

Canary Foundation is a non-profit dedicated to the goal of identifying cancer early through a simple blood test and then isolating it with imaging. Since 2004, Canary has raised over $30 million to support early detection research. Its collaborative research programs span multiple disciplines and institutions. One hundred percent of donations go to early detection research activities. For more inf...

Early Pregnancy Tests

Early-Pregnancy-Tests.com, we offer the widest selection of fertility and preconception products - including our flagship FDA-Approved pregnancy and ovulation tests. Providing the highest degree of sensitivity available (20 mIU/ml hCG) you receive accurate results sooner. All our pregnancy and ovulation tests are designed for convenient home testing - easy-to-use, reliable, and packaged discreetly...

The Super Jake Foundation

The Super Jake Foundation -- dedicated to helping kids win the battle against cancer -- is a national 501c3 nonprofit organization established to honor Jake Robert Widman, who, at age three, was diagnosed with a rare and deadly form of pediatric cancer called neuroblastoma. Super Jake fought his courageous battle for more than a year, enduring 10 rounds of chemotherapy, four surgeries and three bo...

Early Pregnancy Tests.com

Early Pregnancy Tests is committed to protecting your privacy. As such, we maintain the following privacy policy to protect your personal information.Confidentiality Policy: Your name, credit card number, postal and e-mail address, telephone number, and the items you purchase from us are kept private and confidential on a safe (secure) server. No Release of Information to Third Parties: Early Preg...

Propel Technology

PROPEL is a group of programs aimed at increasing the number and success rate of early-stage life sciences companies in Illinois. PROPEL helps guide the development of formation-stage and early-stage life sciences companies by providing entrepreneurs with access to specialized resources and expertise to prepare them for early-stage funding. PROPEL is a Cen...

Acuamark Diagnostics, Inc.

Acuamark Diagnostics is a biotechnology company focused on developing screening tests for blood-based early detection of cancer. Acuamark Diagnostics' technology allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable. Backed by a highly experienced team, it is Acuamark Diagno...

TFF Pharmaceuticals, Inc.

TFF Pharmaceuticals, Inc. is an early-stage biopharmaceutical company focused on the development and commercialization of new inhalation products for the treatment of chronic respiratory diseases and lung conditions. In early testing the Thin Film Freezing (TFF) proprietary platform significantly improved the solubility of drugs that have poor water solubi...

Richmond Pharmacology Ltd

Our goal is to deliver full service Early Phase clinical solutions swiftly, efficiently, and to the highest clinical standard. Our integrated set-up is designed to manage your Early Phase study within the controlled environment of Phase I. We compliment this through our out-patient facilities offering flexibility through the Phases in clinical trials.“Richmond Pharmacology is the UK's only Early...

Xontogeny LLC

Xontogeny was founded by industry veteran Chris Garabedian and launched with a $25M Series A round in May 2017. The company, based in Boston, MA, seeks to support and accelerate the development of life science technologies from early development through clinical proof-of-concept. Xontogeny provides entrepreneurs with the leadership, strategic guidance and ...

EDP Biotech Corporation

EDP Biotech (EDP) is a medical device company focused on the development and sale of immunodiagnostic tests for both humans and animals. EDP utilizes more than 30 years of research and development in the identification and purification of proteins present in the early stages of biological changes for production of in vitro diagnostics test whose primary ta...

Santarus, Inc.

Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists, endocrinologists and other physicians. The company’s current commercial efforts are focused on GLUMETZA® (metformin HCl extended release tablets), which ...

Onconome, Inc.

Onconome is dedicated to the discovery, development and commercialization of innovative biomarkers for the early and accurate detection of prostate, colon, bladder and other forms of cancer, including lung, breast, liver, pancreatic and stomach. Early detection is the key to successful treatment. Our serum tests for early detection of prostate and colon cancer and our urine test for bladder cancer...

Universal Diagnostics

Universal Diagnostics (UDX) is an innovative biomedicine company focused on early detection of cancer. By combining world-leading expertise in metabolomics with advanced bioinformatics, UDX is developing simple to use, non-invasive tests to detect cancers early. The first test in development is for the detection of colorectal cancer and precancerous adenom...

Fischer Imaging

Fischer was founded in 1910 by H.G. Fischer - merely nine years after Wilhelm Roentgen was awarded the Nobel Prize for his discovery of the X-ray. The oldest existing manufacturer of X-ray medical equipment in the United States, Fischer has advanced the technology from its early uses for discovery of tuberculosis, the most common cause of death in the early 20th century, to a more recent applicat...

Novigenix SA

Novigenix SA is an innovative Swiss molecular diagnostics company focused on the commercialization of new screening and diagnostics tools for early detection of cancer. Novigenix’s products rely on a new generation of predictive molecular signatures and state-of-the-art mathematical analytical models to provide new solutions for the early diagnosis of...

Johnson & Johnson Innovation

The London Innovation Centre is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Limited. Johnson & Johnson Innovation focuses on accelerating early innovation and enhancing opportunities for collaboration and investment across Johnson & Johnson’s global healthcare businesses. Johnson & Johnson Innovation provides scientis...

Bright Horizons Family Solutions

Bright Horizons Family Solutions® (www.brighthorizons.com) is the world's leading provider of employer-sponsored child care, early education and work/life solutions. Bright Horizons® serves more than 800 clients across the U.S., Europe, and Canada, with programs including child care and early education, back-up care, elder care, college counseling, and work/life consulting. The company operates...


More From BioPortfolio on "Tocilizumab REMission in Early RA"

Quick Search

Corporate Database Quicklinks